LOANS for Biomedical Research Act

House Bill 7539 - LOANS for Biomedical Research Act: Overview, Status, and Impact

Hozzl · 2024-03-27T20:15:23Z

Explore the details of House Bill 7539 LOANS for Biomedical Research Act currently in Congress. Get insights into its purpose, current status, sponsors, and potential impact on Health. Stay informed on legislative developments.

3/27/2024, 8:15 PM

Read the Full Bill

Formatted Text PDF Formatted XML

Current Status of Bill HR 7539

Bill HR 7539 is currently in the status of Bill Introduced since March 5, 2024. Bill HR 7539 was introduced during Congress 118 and was introduced to the House on March 5, 2024. Bill HR 7539's most recent activity was Referred to the House Committee on Energy and Commerce. as of March 5, 2024

Bipartisan Support of Bill HR 7539

Total Number of Sponsors

Democrat Sponsors

Republican Sponsors

Unaffiliated Sponsors

Total Number of Cosponsors

Democrat Cosponsors

Republican Cosponsors

Unaffiliated Cosponsors

Policy Area and Potential Impact of Bill HR 7539

Primary Policy Focus

Health

Alternate Title(s) of Bill HR 7539

LOANS for Biomedical Research Act

To require the Secretary of the Treasury to guarantee BioBonds in order to provide funding for loans to eligible biomedical companies and universities to carry out clinical trials approved by the Food and Drug Administration, and for other purposes.

LOANS for Biomedical Research Act

Long-term Opportunities for Advancing New Studies for Biomedical Research Act